Ashton Davis
Medical · Johnstown, OHNPI 1922872175
Payments from drug & device makers
Across 98 payments — averaging $16.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$263
- AbbVie$211
- Lilly USA, LLC$179
- Novo Nordisk$141
- Exact Sciences$99
- Boehringer Ingelheim$94
- plus $618 from 17 others
What the payments were for
- Food & beverage$1,604100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 14 | $263 |
| AbbVie | 22 | $211 |
| Lilly USA, LLC | 10 | $179 |
| Novo Nordisk | 8 | $141 |
| Exact Sciences | 4 | $99 |
| Boehringer Ingelheim | 5 | $94 |
| Johnson & Johnson | 4 | $83 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $80 |
| Amgen | 5 | $77 |
| Pfizer | 3 | $57 |
| Bayer | 2 | $49 |
| Radius Health, Inc. | 3 | $49 |
| Dexcom, Inc. | 2 | $37 |
| Cequr Corporation | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Bard Peripheral Vascular, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Merck | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Tandem Diabetes Care, Inc. | 2 | $16 |
| Corcept Therapeutics | 1 | $14 |
| Averitas Pharma Inc. | 1 | $13 |
How this compares
$1,604 in reported general payments places this provider in the 70th percentile of 547 medical providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 19 | $18,787 |
| OzempicSemaglutide | 12 | $14,312 |
| JardianceEmpagliflozin | 12 | $8,105 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 48 | $883 |
| Ondansetron Hcl | 12 | $746 |
| SynthroidLevothyroxine Sodium | 11 | $656 |
| Levothyroxine Sodium | 57 | $642 |
| Atorvastatin Calcium | 52 | $578 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $563 |
| Pregabalin | 12 | $556 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 50 | $545 |
| Hydroxyzine Hcl | 18 | $461 |
| Duloxetine Hcl | 17 | $419 |
| Doxycycline Monohydrate | 25 | $414 |
| Methocarbamol | 18 | $362 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $179 | $18,78719 claims |
| Novo NordiskOzempic | $141 | $14,31212 claims |
| Boehringer IngelheimJardiance | $94 | $8,10512 claims |
| AbbVieSynthroid | $211 | $65611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 547 medical providers in Ohio.
Other medical in Johnstown
- Shannon GhizzoniColumbus$116K
- Susan WhittCanal Winchester$74K
- Christopher FrickLima$46K
- Kodi VealeAkron$43K
- Abbey BlairCleveland$24K
- Joana ZulaConcord Twp$23K
- Chelsea AustenColumbus$21K
- Kristen FairchildToledo$19K
- Kaitlin SchuppGahanna$17K
- Melanie HunglerCincinnati$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.